Your browser is no longer supported. Please, upgrade your browser.
EFTR [NASD]
eFFECTOR Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.10 Insider Own12.10% Shs Outstand16.70M Perf Week-0.82%
Market Cap271.73M Forward P/E- EPS next Y-0.92 Insider Trans-11.60% Shs Float9.82M Perf Month9.52%
Income- PEG- EPS next Q-0.24 Inst Own69.30% Short Float3.79% Perf Quarter-44.27%
Sales1.16M P/S234.05 EPS this Y- Inst Trans0.22% Short Ratio2.18 Perf Half Y-26.77%
Book/sh-0.46 P/B- EPS next Y-127.50% ROA- Target Price28.60 Perf Year-
Cash/sh1.46 P/C4.96 EPS next 5Y- ROE- 52W Range5.50 - 40.42 Perf YTD-12.44%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-82.06% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin- 52W Low31.82% ATR0.72
Employees- Current Ratio1.30 Sales Q/Q-25.60% Oper. Margin- RSI (14)44.74 Volatility8.19% 10.41%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.23 Prev Close6.73
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume170.83K Price7.25
Recom1.80 SMA20-7.97% SMA50-9.88% SMA200-30.84% Volume39,204 Change7.73%
Nov-09-21Upgrade Stifel Hold → Buy $20
Oct-12-21Initiated Credit Suisse Outperform $20
Oct-04-21Initiated Mizuho Buy $20
Sep-21-21Initiated JMP Securities Mkt Outperform $33
Sep-20-21Initiated Stifel Hold $20
Sep-13-21Initiated Cantor Fitzgerald Overweight $50
Nov-24-21 08:00AM  
Nov-22-21 08:00AM  
Nov-08-21 07:00AM  
Nov-04-21 09:08AM  
Nov-01-21 04:05PM  
Oct-26-21 08:00AM  
Oct-07-21 04:30PM  
Sep-30-21 04:32PM  
Sep-16-21 08:00AM  
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROOT JONATHAN DDirectorDec 02Sale5.688,11346,082140,261Dec 06 07:28 PM
Presidio Management Group X LL10% OwnerDec 02Sale5.688,11346,082140,261Dec 06 07:27 PM
ROOT JONATHAN DDirectorDec 01Sale6.4419,245123,880140,513Dec 01 06:31 PM
Presidio Management Group X LL10% OwnerDec 01Sale6.4419,245123,880140,513Dec 01 06:31 PM
ROOT JONATHAN DDirectorNov 30Sale6.5327,409179,036141,110Dec 01 06:31 PM
Presidio Management Group X LL10% OwnerNov 30Sale6.5327,409179,036141,110Dec 01 06:31 PM
ROOT JONATHAN DDirectorNov 29Sale6.7025,764172,490141,960Dec 01 06:31 PM
Presidio Management Group X LL10% OwnerNov 29Sale6.7025,764172,490141,960Dec 01 06:31 PM
Presidio Management Group X LL10% OwnerNov 26Sale7.015,02635,242142,759Nov 26 04:43 PM
ROOT JONATHAN DDirectorNov 26Sale7.015,02635,242142,759Nov 26 04:44 PM
Presidio Management Group X LL10% OwnerNov 24Sale7.3636,520268,605142,915Nov 26 04:43 PM
ROOT JONATHAN DDirectorNov 24Sale7.3636,520268,605142,915Nov 26 04:44 PM
Presidio Management Group X LL10% OwnerNov 23Sale7.4014,879110,150144,047Nov 26 04:43 PM
ROOT JONATHAN DDirectorNov 23Sale7.4014,879110,150144,047Nov 26 04:44 PM
ROOT JONATHAN DDirectorNov 22Sale7.8626,183205,798144,508Nov 22 07:13 PM
Presidio Management Group X LL10% OwnerNov 22Sale7.8626,183205,798144,508Nov 22 07:12 PM
ROOT JONATHAN DDirectorNov 19Sale8.127,24158,804145,320Nov 22 07:13 PM
Presidio Management Group X LL10% OwnerNov 19Sale8.127,24158,804145,320Nov 22 07:12 PM
ROOT JONATHAN DDirectorNov 18Sale8.5316,745142,801145,544Nov 22 07:13 PM
Presidio Management Group X LL10% OwnerNov 18Sale8.5316,745142,801145,544Nov 22 07:12 PM
ROOT JONATHAN DDirectorNov 17Sale9.1310,23593,415146,063Nov 17 07:56 PM
Presidio Management Group X LL10% OwnerNov 17Sale9.1310,23593,415146,063Nov 17 07:55 PM
ROOT JONATHAN DDirectorNov 16Sale9.428,31978,357146,380Nov 17 07:56 PM
Presidio Management Group X LL10% OwnerNov 16Sale9.428,31978,357146,380Nov 17 07:55 PM
ROOT JONATHAN DDirectorNov 15Sale9.815,07149,751146,637Nov 17 07:56 PM
Presidio Management Group X LL10% OwnerNov 15Sale9.815,07149,751146,637Nov 17 07:55 PM
ROOT JONATHAN DDirectorNov 12Sale10.0712,000120,840146,794Nov 12 05:53 PM
Presidio Management Group X LL10% OwnerNov 12Sale10.0712,000120,840146,794Nov 12 05:52 PM
ROOT JONATHAN DDirectorNov 11Sale10.3712,017124,592147,166Nov 12 05:53 PM
Presidio Management Group X LL10% OwnerNov 11Sale10.3712,017124,592147,166Nov 12 05:52 PM
ROOT JONATHAN DDirectorNov 10Sale10.4434,000354,824147,539Nov 12 05:53 PM
Presidio Management Group X LL10% OwnerNov 10Sale10.4434,000354,824147,539Nov 12 05:52 PM
ROOT JONATHAN DDirectorNov 09Sale11.0028,785316,750148,593Nov 12 05:53 PM
Presidio Management Group X LL10% OwnerNov 09Sale11.0028,785316,750148,593Nov 12 05:52 PM